ClearPoint Neuro en UCB gaan licentieovereenkomst aan voor toediening van gentherapiegeneesmiddelen
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californië, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), een multinational die platforms ontwikkelt voor therapie met navigatie naar en levering aan de...
ClearPoint Neuro y UCB firman un acuerdo de licencia para la administración de fármacos de terapia génica
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), una empresa global de plataformas habilitadoras de terapias que ofrecen navegación y administración...
ClearPoint Neuro e UCB stipulano un contratto di licenza per la somministrazione di farmaci per la terapia genetica
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), società globale di piattaforme terapeutiche che fornisce navigazione e somministrazione al cervello,...
ClearPoint Neuro et UCB concluent un accord de licence pour l'administration de médicaments de thérapie génique
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 25 mai 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers...
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 24, 2023 09:25 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...
ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
May 18, 2023 16:01 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports First Quarter 2023 Results
May 11, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
May 10, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
April 28, 2023 16:42 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System
April 20, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...